Advertisement
Sales of the migraine treatment skin patch Zecuity (sumatriptan iontophoretic transdermal system) have been halted after patients reported suffering burns and scars where the patches were applied

Sales of Zecuity Migraine Skin Patches Halted

0
Some users have developed skin discoloration, cracked skin, and pain where patches were applied
For patients undergoing elective cranial surgery

Type of Shaving Impacts Body Image in Elective Cranial Sx

0
Infection rate similar for regional, strip shaving; regional shaving adversely affects body image
Many young people who suffer from migraines have vitamin deficiencies

Young Migraine Patients Often Have Vitamin Deficiencies

0
But study couldn't determine if supplements made a difference
American seniors with diabetes are starting to live longer without disabilities

American Seniors With Diabetes Living Longer Without Disability

0
Researchers find increase in 'good' years of life in recent decades
Many newly infected HIV patients experience neurological symptoms

Newly-Infected HIV Patients Often Display Neurologic Systems

0
But symptoms tend to subside once antiretroviral drugs are given
More than half of patients prescribed opioids receive more than they need

Many Patients Prescribed Opioids Sharing Leftover Pills

0
Two new U.S. studies shed additional light on opioid epidemic
Patients taking systemic glucocorticoids are at higher risk for community-acquired Staphylococcus aureus bacteremia

Risk of S. aureus Bacteremia Up in Patients on Glucocorticoids

0
Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage
A treatment combining chemotherapy and an autologous hematopoietic stem-cell transplantation could represent a major advance against aggressive multiple sclerosis

New Post-Chemo Stem Cell Transplant Promising in MS

0
However, toxic side effects of strong chemo could limit use
In order to avoid having infants with Zika-related birth defects

WHO Advises Delaying Pregnancy in Zika-Affected Areas

0
However, the CDC has decided against this kind of recommendation in the United States
An experimental drug -- TEV-48125 -- brings fast relief to patients with debilitating chronic migraines

Faster Results for Experimental Rx in Chronic Migraine

0
TEV-48125 begins working within three to seven days